Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice

Journal of Gastroenterology

Volumn 44, Issue 3, 2009, Pages 218-227

  Kimura, Kiminori ^a,b   Nagaki, Masahito ^c   Saio, Masanao ^c   Moriwaki, Hisataka ^c   Kakimi, Kazuhiro ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute hepatitis; CD44; CTL; HBV

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD86 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CELL LABELING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HEPATITIS B VIRUS; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; LIVER SINUSOID; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRUS IMMUNITY;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD44; APOPTOSIS; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; INTERFERON-GAMMA; LIVER; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60449108515     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2300-8     Document Type: Article

References (31)

1. Kimura K, Nagaki M, Nishihira J, Satake S, Kuwata K, Moriwaki H. Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury. Clin Vaccine Immunol 2006;13:415-419.
2. Takai S, Kimura K, Nagaki M, Satake S, Kakimi K, Moriwaki H. Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice. J Virol 2005;79:15142-15150.
3. Sitia G, Isogawa M, Kakimi K, Wieland SF, Chisari FV, Guidotti LG. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 2002;99:13717-13722.
4. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
5. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995;57:827-872.
6. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003;4:33-45.
7. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A 1999;96:6896-6901.
8. Katoh S, Matsumoto N, Kawakita K, Tominaga A, Kincade PW, Matsukura S. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest 2003;111:1563-1570.
9. McKallip RJ, Fisher M, Gunthert U, Szakal AK, Nagarkatti PS, Nagarkatti M. Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage. Infect Immun 2005;73:50-61.
10. Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1995;1:558-563.
11. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997;90:2217-2233.
12. Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 2002;161:2219-2228.
13. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993;178:1541-1554.
14. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996;4:25-36.
15. Kimura K, Nagaki M, Takai S, Satake S, Moriwaki H. Pivotal role of nuclear factor kappa B signaling in anti-CD40-induced liver injury in mice. Hepatology 2004;40:1180-1189.
16. Kimura K, Nagaki M, Kakimi K, Saio M, Saeki T, Okuda Y, et al. Critical role of CD44 in hepatotoxin-mediated liver injury. J Hepatol 2008;48:952-961.
17. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3:51-62.
18. Knolle P, Lohr H, Treichel U, Dienes HP, Lohse A, Schlaack J, et al. Parenchymal and nonparenchymal liver cells and their interaction in the local immune response. Z Gastroenterol 1995;33:613-620.
19. Knolle PA, Gerken G, Loser E, Dienes HP, Gantner F, Tiegs G, et al. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996;24:824-829.
20. Nagaki M, Naiki T, Brenner DA, Osawa Y, Imose M, Hayashi H, et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: Role of nuclear factor-kappa B. Hepatology 2000;32:1272-1279.
21. Satake S, Nagaki M, Kimura K, Moriwaki H. Inhibition of nuclear factor-kappa B induces inflammatory cell migration and exacerbates severe liver injury in hepatitis B virus transgenic mice. Hepatol Res 2007;37:524-530.
22. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, et al. Resolution of lung inflammation by CD44. Science 2002;296:155-158.
23. Vachon E, Martin R, Plumb J, Kwok V, Vandivier RW, Glogauer M, et al. CD44 is a phagocytic receptor. Blood 2006;107:4149-4158.
24. Kraal G, Mebius RE. High endothelial venules: Lymphocyte traffic control and controlled traffic. Adv Immunol 1997;65:347-395.
25. Siegelman MH, DeGrendele HC, Estess P. Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 1999;66:315-321.
26. Stoolman LM. Adhesion molecules controlling lymphocyte migration. Cell 1989;56:907-910.
27. Cichy J, Pure E. The liberation of CD44. J Cell Biol 2003;161:839-843.
28. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol 1999;52:189-196.
29. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-512.
30. Allouche M, Charrad RS, Bettaieb A, Greenland C, Grignon C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 2000;96:1187-1190.
31. Lakshman M, Subramaniam V, Jothy S. CD44 negatively regulates apoptosis in murine colonic epithelium via the mitochondrial pathway. Exp Mol Pathol 2004;76:196-204.